資料載入處理中...
臺灣人文及社會科學引文索引資料庫系統
:::
網站導覽
國圖首頁
聯絡我們
操作說明
English
行動版
(18.188.166.246)
登入
字型:
**字體大小變更功能,需開啟瀏覽器的JAVASCRIPT,如您的瀏覽器不支援,
IE6請利用鍵盤按住ALT鍵 + V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小,
如為IE7以上、Firefoxy或Chrome瀏覽器則可利用鍵盤 Ctrl + (+)放大 (-)縮小來改變字型大小。
來源文獻查詢
引文查詢
瀏覽查詢
作者權威檔
引用/點閱統計
我的研究室
資料庫說明
相關網站
來源文獻查詢
/
簡易查詢
/
查詢結果列表
/
詳目列表
:::
詳目顯示
第 1 筆 / 總合 1 筆
/1
頁
來源文獻資料
引文資料
題名:
Patient Characteristics and Treatment Discontinuation in a Taiwanese Cohort of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study
書刊名:
Taiwanese Journal of Psychiatry
作者:
林喬祥
/
蕭正誠
/
黃玉書
/
呂少鈞
/
盧孟良
/
臧汝芬
/
魯思翁
/
West, Teena Maree
/
沈武典
作者(外文):
Lin, Chaucer Chiao-hsiang
/
Hsiao, Cheng-cheng
/
Huang, Yu-shu
/
Ree, Shao-chun
/
Lu, Mong-liang
/
Tzang, Ruu-fen
/
Luu, Sy-ueng
/
Shen, Winston W.
出版日期:
2010
卷期:
24:2
頁次:
頁110-121+162
主題關鍵詞:
精神分裂症
;
觀察性研究
;
治療中斷時間
;
Schizophrenia
;
Observational study
;
Time to discontinuation
;
Olanzapine
原始連結:
連回原系統網址
相關次數:
被引用次數:期刊(
1
) 博士論文(0) 專書(0) 專書論文(0)
排除自我引用:
1
共同引用:0
點閱:59
期刊論文
1.
Csernansky, J. G.、Schuchart, E. K.(2002)。Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics。CNS Drugs,16,473-484。
2.
Tan, Chay H.、Shinfuku, Naotaka、Si, Tianmei、Ungvari, Gabor S.、Chung, Eun K.、Sim, Kang、Su, Alex、Heckers, Stephan、Chan, Yiong H.、曾憲洋、張明永、楊淑媛、Fujii, Senta(2004)。Antipsychotic Polypharmacy in Patients with Schizophrenia: A Multicentre Comparative Study in East Asia。British Journal of Clinical Pharmacology,58(2),178-183。
3.
Miyamoto S,、Duncan GE,、Marx CE,、Lieberman JA.(2005)。Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs。Mol Psychiatry,10,79-104。
4.
蘇東平、陳曾基、黃信彰、周麗芳、范佩真、陳育群(20020800)。Utilization of Psychotropic Drugs in Taiwan: An Overview of Outpatient Sector in 2000。中華醫學雜誌,65(8),378-391+CA62。
延伸查詢
5.
Tollefson GD, Sanger TM(1997)。Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine。Am J Psychiatry,154,466-74。
6.
Shen, Winston W.(2004)。Antidepressants are under-used in Taiwan。臺灣精神醫學,18(2),77-78。
7.
EuroQol Group(1990)。A new facility for the measurement of health-related quality of life。Health Policy,16(3),199-208。
8.
Lieberman, J. A.、Stroup, T. S.、McEvoy, J. P.、Swartz, M. S.、Rosenheck, R. A.、Perkins, D. O.、Hsiao, J. K.(2005)。Effectiveness of antipsychotic drugs in patients with chronic schizophrenia。New England Journal of Medicine,353(12),1209-1223。
9.
American Psychiatric Association(1997)。Practice guideline for the treatment of patients with schizphrenia。Am J Psychiatry,154 (Suppl 2),1-63。
10.
Sullivan G, Wells KB, Morgenstern H, Leake B(1995)。Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi。Am J Psychiatry,152,1749-56。
11.
Valenstein M, Copeland LA, Blow FC, et al.(2002)。Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission。Med Care,40,630-9。
12.
Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW(2006)。Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care。J Clin Psychiatry,67,453-60。
13.
Saleem P, Olie JP, Loo H(2002)。Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride。Int Clin Psychoparmacol,17,1-8。
14.
Corrigan PW, Reinke RR, Landsberger SA, Charate A, Toombs GA(2003)。The effects of atypical antipsychotic medications on psychosocial outcomes。Schizophr Res,63,97-101。
15.
Lehman AF, Lieberman JA, Dixon LB, et al.(2004)。Practice guidelines for the treatment of patients with schizophrenia, second edition。Am J Psychiatry,161(Suppl 2),1-56。
16.
Lee P, Kim CE, Kim CY, et al.(2008)。Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO)。Int J Psychiatry Clinical Practice,12(3),215-227。
17.
Lee C, Wu KH, Habil H, Dyachkova Y, Lee P(2006)。Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia。Aust NZ J Psychiatry,40,437-45。
18.
Haro JM, Kamath SA, Ochoa S, et al.(2003)。The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia。Acta Psychiatr Scand,Suppl,16-23。
19.
Huang SS, Liao YC, Hsieh YY, et al(2006)。Combination antipsychotic therapy in psychiatric outpatients clinics in Taiwan。Compr Psychiatry,47,421-5。
20.
Shen WW(1981)。A drug information note for patients receiving antiparkinsonian agents。Hosp Community Psychiatry,32,575。
21.
Keck PE Jr, Strakowski SM, McElroy SL(2000)。The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia。J Clin Psychiatry,61 (Suppl 3),4-9。
22.
Kelly DL, Conley RR, Carpenter WT(2005)。First-episode schizophrenia: a focus on pharmacological treatment and safety considerations。Drugs,65,1113-38。
23.
Sebastian CS, Glazer W, Buckley PF(2004)。Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia。Curr Med Chem,11,329-42。
24.
Tran PV, Hamilton SH, Kuntz AJ, et al.(1997)。Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders。J Clin Psychopharmacol,17,407-18。
25.
Kahn RS, Fleischhacker WW, Boter H, et al.(2008)。Effectiveness of antipsychotic drugs in first episode schizophrenia and schizophreniform disorder: an open randomised clinical trial。Lancet,371,1085-1097。
26.
Basson BR, Kinon BJ, Tor CC, Szymanski KA, Gilmore JA, Tollefson GD(2001)。Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone。J Clin Psychiatry,62,231-8。
27.
Allison DB, Casey DE(2001)。Antipsychotic-induced weight gain: a review of the literature。J Clin Psychiatry,62 (Suppl 7),22-31。
28.
Weiden PJ, Mackell JA, McDonnell DD(2004)。Obesity as a risk factor for antipsychotic noncompliance。Schizophr Res,66,51-7。
29.
Bobes J, Rejas J, Garcia-Garcia M, et al(2003)。Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study。Schizophr Res,62,77-88。
推文
當script無法執行時可按︰
推文
推薦
當script無法執行時可按︰
推薦
引用網址
當script無法執行時可按︰
引用網址
引用嵌入語法
當script無法執行時可按︰
引用嵌入語法
轉寄
當script無法執行時可按︰
轉寄
top
:::
相關期刊
相關論文
相關專書
相關著作
熱門點閱
1.
Changing Patterns of Antipsychotic Prescription and Concomitant Antiparkinson Drug Use at a Taiwanese Psychiatric Hospital
無相關博士論文
無相關書籍
無相關著作
無相關點閱
QR Code